Brain Tumor Reports

Volume 11 Number 3
March 2009

Home > Publications > Brain Tumor Reports > Volume 11, Year 2009 > Number 3, March°



Li A, Walling J, Ahn S, Kotliarov Y, Su Q, Quezado M, Oberholtzer JC, Park J, Zenklusen JC, Fine HA
Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes
Cancer Res. 2009 Feb 24;. [Epub ahead of print]


Feldman SC, Chu D, Schulder M, Barry M, Cho ES, Liu WC
The blood oxygen level-dependent functional MR imaging signal can be used to identify brain tumors and distinguish them from normal tissue.
AJNR Am J Neuroradiol. 2009 Feb;30(2):389-95

Pirotte BJ, Levivier M, Goldman S, Massager N, Wikler D, Dewitte O, Bruneau M, Rorive S, David P, Brotchi J
Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients
Neurosurgery. 2009 Mar;64(3):471-81


Coble JB, Dosemeci M, Stewart PA, Blair A, Bowman J, Fine HA, Shapiro WR, Selker RG, Loeffler JS, Black PM, Linet MS, Inskip PD.
Occupational exposure to magnetic fields and the risk of brain tumors
Neuro Oncol. 2009 Feb 20; [Epub ahead of print]

Schmidt LS, Grell K, Frederiksen K, Johansen C, Schmiegelow K, Schüz J
Seasonality of birth in children with central nervous system tumours in Denmark, 1970-2003
Br J Cancer. 2009 Jan 13;100(1):185-7. Epub 2008 Dec 9
  Abstract |   Full Text |   Reprint

Etiology & Pathogenesis

Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A
Analysis of the IDH1 codon 132 mutation in brain tumors
Acta Neuropathol. 2008 Dec;116(6):597-602. Epub 2008 Nov 5
  Abstract |   Full Text |   Reprint

Guo H, Gu F, Li W, Zhang B, Niu R, Fu L, Zhang N, Ma Y
Reduction of Protein kinase C zeta inhibits migration and invasion of human glioblastoma cells
J Neurochem. 2009 Feb 2. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Kouwenhoven MC, Gorlia T, Kros JM, Ibdaih A, Brandes AA, Bromberg JE, Mokhtari K, van Duinen SG, Teepen JL, Wesseling P, Vandenbos F, Grisold W, Sipos L, Mirimanoff R, Vecht CJ, Allgeier A, Lacombe D, van den Bent MJ
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951
Neuro Oncol. 2009 Feb 17. [Epub ahead of print]

Majores M, von Lehe M, Fassunke J, Schramm J, Becker AJ, Simon M
Tumor recurrence and malignant progression of gangliogliomas
Cancer. 2008 Dec 15;113(12):3355-63

Muragaki Y, Chernov M, Tajika Y, Kubo O, Iseki H, Hori T, Takakura K
Coincidence of central neurocytoma and multiple glioblastomas: a rare case report
J Neurooncol. 2009 Jan 29. [Epub ahead of print]

Rieske P, Golanska E, Zakrzewska M, Piaskowski S, Hulas-Bigoszewska K, Wolanczyk M, Szybka M, Witusik-Perkowska M, Jaskolski DJ, Zakrzewski K, Biernat W, Krynska B, Liberski PP
Arrested neural and advanced mesenchymal differentiation of glioblastoma cells- comparative study with neural progenitors
BMC Cancer. 2009 Feb 14;9(1):54. [Epub ahead of print]
  Abstract |   Reprint

Watanabe T, Nobusawa S, Kleihues P, Ohgaki H
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
Am J Pathol. 2009 Feb 26. [Epub ahead of print]

Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD.
IDH1 and IDH2 mutations in gliomas
N Engl J Med. 2009 Feb 19;360(8):765-73

Integrative Medicine

Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, Chen TC, Schonthal AH
Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors
Blood. 2009 Feb 3; [Epub ahead of print]

Pogoda JM, Preston-Martin S, Howe G, Lubin F, Mueller BA, Holly EA, Filippini G, Peris-Bonet R, McCredie MR, Cordier S, Choi W.
An international case-control study of maternal diet during pregnancy and childhood brain tumor risk: a histology-specific analysis by food group
Ann Epidemiol. 2009 Mar;19(3):148-60

Terry MB, Howe G, Pogoda JM, Zhang FF, Ahlbom A, Choi W, Giles GG, Little J, Lubin F, Menegoz F, Ryan P, Schlehofer B, Preston-Martin S
An international case-control study of adult diet and brain tumor risk: a histology-specific analysis by food group
Ann Epidemiol. 2009 Mar;19(3):161-71

Overall Management

Binello E, Germano IM
Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology?
J Neurooncol. 2009 Feb 7. [Epub ahead of print]

Bromberg JE, van den Bent MJ
Oligodendrogliomas: Molecular Biology and Treatment
Oncologist. 2009 Jan 31. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Buhl R, Stark AM, Hugo HH, Rohr A, Mehdorn HM
Gliosarcoma: clinical experiences and additional information with MR spectroscopy
Neurol Res. 2009 Feb 12; [Epub ahead of print]

Campbell BA, Jhamb A, Maguire JA, Toyota B, Ma R
Meningiomas in 2009: controversies and future challenges
Am J Clin Oncol. 2009 Feb;32(1):73-85

Campos S, Davey P, Hird A, Pressnail B, Bilbao J, Aviv RI, Symons S, Pirouzmand F, Sinclair E, Culleton S, Desa E, Goh P, Mbbs EC
Brain metastasis from an unknown primary, or primary brain tumour? A diagnostic dilemma
Curr Oncol. 2009 Jan;16(1):62-6
  Abstract |   Full Text |   Reprint

Frisullo G, Patanella AK, Nociti V, Cianfoni A, Iorio R, Bianco A, Marti A, Tonali PA, Batocchi AP
Glioblastoma in multiple sclerosis: a case report
J Neurooncol. 2009 Feb 13. [Epub ahead of print]

Gezen F, Karatas A, Is M, Yildirim U, Aytekin H
Giant cavernous haemangioma in an infant
Br J Neurosurg. 2008 Dec;22(6):787-9

Hochwald O, McFadden DE, Osiovich H, Dunham C.
Congenital Gliosarcoma: Detailed Clinicopathologic Documentation of a Rare Neoplasm
Pediatr Dev Pathol. 2009 Feb 26; [Epub ahead of print]

Johnston DL, Keene D, Bartels U, Carret AS, Crooks B, Eisenstat DD, Fryer C, Lafay-Cousin L, Larouche V, Moghrabi A, Wilson B, Zelcer S, Silva M, Brossard J, Bouffet E
Medulloblastoma in children under the age of three years: a retrospective Canadian review
J Neurooncol. 2009 Jan 31. [Epub ahead of print]
  Abstract |   Reprint |   Related articles

Miliaras G, Tsitsopoulos PP, Markoula S, Kyritsis A, Polyzoidis KS, Malamou-Mitsi V
Multifocal glioblastoma with remote cutaneous metastasis: a case report and review of the literature
Zentralbl Neurochir. 2009 Feb;70(1):39-42

Mirone G, Schiabello L, Chibbaro S, Bouazza S, George B
Pediatric primary pilocytic astrocytoma of the cerebellopontine angle: a case report
Childs Nerv Syst. 2009 Feb;25(2):247-51. Epub 2008 Aug 9

Oztanir N, Emmez H, Aytar MH, Dogan M, Kaymaz M, Baykaner MK
Malignant intracerebral giant nerve sheath tumor in a 14-month-old girl with neurofibromatosis type 1: a case report
Childs Nerv Syst. 2009 Feb;25(2):253-6. Epub 2008 Oct 30

Sarica FB, Tufan K, Sen O, Erdogan B.
Therapeutic Difficulty in a Case of Supratentorial Primitive Neuroectodermal Tumor Diagnosed during Pregnancy
J Korean Neurosurg Soc. 2009 Jan;45(1):39-42
  Abstract |   Full Text |   Reprint

Shamji MF, Benoit BG, Perry A, Jansen GH
Giant cell ependymoma of the thoracic spine: pathology case report
Neurosurgery. 2009 Mar;64(3):E566-7


Labbé D, Provençal M, Lamy S, Boivin D, Gingras D, Béliveau R
The Flavonols Quercetin, Kaempferol, and Myricetin Inhibit Hepatocyte Growth Factor-Induced Medulloblastoma Cell Migration
J Nutr. 2009 Feb 25. [Epub ahead of print]


Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, Rumboldt Z
Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for the Prime Time in Predicting Short-Term Outcome and Recurrent Disease?
AJNR Am J Neuroradiol. 2009 Jan 29. [Epub ahead of print]

Chaichana KL, McGirt MJ, Niranjan A, Olivi A, Burger PC, Quinones-Hinojosa A
Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature
Neurol Res. 2009 Feb 12. [Epub ahead of print]

Chamberlain MC, Johnston SK, Glantz MJ
Neoplastic meningitis-related prognostic significance of the Karnofsky performance status
Arch Neurol. 2009 Jan;66(1):74-8

Fischer Jde S, Carvalho PC, Neves-Ferreira AG, da Fonseca CO, Perales J, Carvalho Mda G, Domont GB.
Anti-thrombin as a prognostic biomarker candidate for patients with recurrent glioblastoma multiform under treatment with perillyl alcohol
J Exp Ther Oncol. 2008;7(4):285-90

Stem Cells

Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L, Paz N, Koren-Michowitz M, Waldman D, Leider-Trejo L, Toren A, Constantini S, Rechavi G
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient
PLoS Med. 2009 Feb 17;6(2):e1000029
  Abstract |   Full Text |   Reprint

Bertrand J, Begaud-Grimaud G, Bessette B, Verdier M, Battu S, Jauberteau MO
Cancer stem cells from human glioma cell line are resistant to Fas-induced apoptosis
Int J Oncol. 2009 Mar;34(3):717-27

Capper D, Gaiser T, Hartmann C, Habel A, Mueller W, Herold-Mende C, von Deimling A, Siegelin MD
Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation
Acta Neuropathol. 2009 Feb 12; [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Casalbore P, Budoni M, Ricci-Vitiani L, Cenciarelli C, Petrucci G, Milazzo L, Montano N, Tabolacci E, Maira G, Larocca LM, Pallini R.
Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1
PLoS ONE. 2009;4(2):e4434. Epub 2009 Feb 11
  Abstract |   Full Text |   Reprint

Gallia GL, Tyler BM, Hann CL, Siu IM, Giranda VL, Vescovi AL, Brem H, Riggins GJ
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
Mol Cancer Ther. 2009 Feb;8(2):386-93. Epub 2009 Feb 10

James D, Cavenee W.
Stem Cells for Treating Glioblastoma: How Close to Reality?
Neuro Oncol. 2009 Feb 23; [Epub ahead of print]

Lu KH, Chen YW, Tsai PH, Tsai ML, Lee YY, Chiang CY, Kao CL, Chiou SH, Ku HH, Lin CH, Chen YJ
Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells
Childs Nerv Syst. 2009 Feb 19. [Epub ahead of print]

Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W, Qi Q, Lu N, Tao L, Wang XT, You QD, Guo QL
Isolation and characterization of cancer stem like cells in human glioblastoma cell lines
Cancer Lett. 2009 Feb 14; [Epub ahead of print]

Tchoghandjian A, Baeza N, Colin C, Cayre M, Metellus P, Beclin C, Ouafik L, Figarella-Branger D.
A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties
Brain Pathol. 2009 Feb 20;. [Epub ahead of print]
  Abstract |   Full Text |   Reprint


Clinical Investigations

Banissi C, Ghiringhelli F, Chen L, Carpentier AF
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
Cancer Immunol Immunother. 2009 Feb 17; [Epub ahead of print]

Benny O, Menon LG, Ariel G, Goren E, Kim SK, Stewman C, Black PM, Carroll RS, Machluf M
Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth
Clin Cancer Res. 2009 Feb 15;15(4):1222-31

Brandes AA, Tosoni A, Franceschi E, Sotti G, Frezza G, Amistà P, Morandi L, Spagnolli F, Ermani M
Recurrence Pattern after Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status
J Clin Oncol. 2009 Mar 10;27(8):1275-9. Epub 2009 Feb 2.
Abstract |   Reprint |   Related articles

Bryant NL, Suarez-Cuervo C, Gillespie GY, Markert JM, Nabors LB, Meleth S, Lopez RD, Lamb LS Jr
Characterization and immunotherapeutic potential of {gamma}{delta} T cells in patients with glioblastoma
Neuro Oncol. 2009 Feb 11; [Epub ahead of print]

Chargari C, Kirova YM, Diéras V, Pena PC, Campana F, Cottu PH, Pierga J, Fourquet A; Institut Curie Breast Cancer Study Group
Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients
J Neurooncol. 2009 Jan 25. [Epub ahead of print]

Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor
J Clin Oncol. 2009 Jan 20;27(3):385-9. Epub 2008 Dec 8

Colombo F, Casentini L, Cavedon C, Scalchi P, Cora S, Francescon P
Cyberknife radiosurgery for benign meningiomas: short-term results in 199 patients
Neurosurgery. 2009 Feb;64(2 Suppl):A7-13

Do L, Pezner R, Radany E, Liu A, Staud C, Badie B
Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):486-91. Epub 2008 Oct 14

Gerstner ER, McNamara MB, Norden AD, Lafrankie D, Wen PY
Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression
J Neurooncol. 2009 Feb 17; [Epub ahead of print]

Glas M, Hundsberger T, Stuplich M, Wiewrodt D, Kurzwelly D, Nguyen-Huu B, Rasch K, Herrlinger U
Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent Glioblastoma
Oncology. 2009 Feb 13;76(3):184-189. [Epub ahead of print]

Glas M, Happold C, Rieger J, Wiewrodt D, Bähr O, Steinbach JP, Wick W, Kortmann RD, Reifenberger G, Weller M, Herrlinger U
Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide
J Clin Oncol. 2009 Feb 2. [Epub ahead of print]

Halatsch ME, Löw S, Hielscher T, Schmidt U, Unterberg A, Vougioukas VI
Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinib
Anticancer Res. 2008 Nov-Dec;28(6A):3725-8

Hara W, Tran P, Li G, Su Z, Puataweepong P, Adler JR Jr, Soltys SG, Chang SD, Gibbs IC
Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma
Neurosurgery. 2009 Feb;64(2 Suppl):A26-32

Kuroda JI, Kuratsu JI, Yasunaga M, Koga Y, Saito Y, Matsumura Y
Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma
Int J Cancer. 2008 Nov 24;. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

La Rocca RV, Mehdorn HM.
Localized BCNU chemotherapy and the multimodal management of malignant glioma
Curr Med Res Opin. 2009 Jan;25(1):149-60

Löw S, Vougioukas VI, Hielscher T, Schmidt U, Unterberg A, Halatsch ME
Pathogenetic pathways leading to glioblastoma multiforme: association between gene expressions and resistance to erlotinib
Anticancer Res. 2008 Nov-Dec;28(6A):3729-32

Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermott MW
Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study
J Neurooncol. 2009 Jan 24. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Lino M, Merlo A.
Translating biology into clinic: the case of glioblastoma
Curr Opin Cell Biol. 2009 Feb 12; [Epub ahead of print]

Makidono A, Kobayashi N, Saida Y, Manabe A, Kawamori J, Suzuki K
Metachronous gliomas following cranial irradiation for mixed germ cell tumors
Childs Nerv Syst. 2009 Feb 27;. [Epub ahead of print]

Maurer GD, Tritschler I, Adams B, Tabatabai G, Wick W, Stupp R, Weller M.
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro
Neuro Oncol. 2009 Feb 16; [Epub ahead of print]

Neyns B, Hoorens A, Stupp R.
Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide
Acta Neurol Belg. 2008 Dec;108(4):131-4

Pettorini BL, Narducci A, de Carlo A, Abet F, Caldarelli M, Massimi L, Tamburrini G, Di Rocco C
Thyroid neoplasm after central nervous system irradiation for medulloblastoma in childhood: report of two cases
Childs Nerv Syst. 2009 Feb 19. [Epub ahead of print]

Pirzkall A, McGue C, Saraswathy S, Cha S, Liu R, Vandenberg S, Lamborn KR, Berger MS, Chang SM, Nelson SJ.
Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma
Neuro Oncol. 2009 Feb 19; [Epub ahead of print]

Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE 2nd, Walker A, Friedman HS
Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
J Clin Oncol. 2009 Feb 9. [Epub ahead of print]

Quinn JA, Jiang SX, Carter J, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE 2nd, Threatt S, Friedman HS
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme
Clin Cancer Res. 2009 Feb 1;15(3):1064-8

Reardon DA, Egorin MJ, Desjardins A, Vredenburgh JJ, Beumer JH, Lagattuta TF, Gururangan S, Herndon JE 2nd, Salvado AJ, Friedman HS
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma
Cancer. 2009 Feb 26;. [Epub ahead of print]

Redmond AJ, Diluna ML, Hebert R, Moliterno JA, Desai R, Knisely JP, Chiang VL
Gamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival
J Neurosurg. 2008 Dec;109 Suppl:99-105

Rosati A, Marconi S, Pollo B, Tomassini A, Lovato L, Maderna E, Maier K, Schwartz A, Rizzuto N, Padovani A, Bonetti B
Epilepsy in glioblastoma multiforme: correlation with glutamine synthetase levels
J Neurooncol. 2009 Jan 30;. [Epub ahead of print]

Rosati A, Tomassini A, Pollo B, Ambrosi C, Schwarz A, Padovani A, Bonetti B
Epilepsy in cerebral glioma: timing of appearance and histological correlations
J Neurooncol. 2009 Jan 29. [Epub ahead of print]

Sathornsumetee S, Reardon DA
Targeting multiple kinases in glioblastoma multiforme
Expert Opin Investig Drugs. 2009 Mar;18(3):277-92

Silvani A, Gaviani P, Lamperti EA, Eoli M, Falcone C, Dimeco F, Milanesi IM, Erbetta A, Boiardi A, Fariselli L, Salmaggi A
Cisplatinum and BCNU chemotherapy in primary glioblastoma patients
J Neurooncol. 2009 Feb 11. [Epub ahead of print]

van den Bent MJ, Brandes AA, Rampling R, Kouwenhoven MC, Kros JM, Carpentier AF, Clement PM, Frenay M, Campone M, Baurain JF, Armand JP, Taphoorn MJ, Tosoni A, Kletzl H, Klughammer B, Lacombe D, Gorlia T
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
J Clin Oncol. 2009 Feb 9. [Epub ahead of print]

Wentworth S, Pinn M, Bourland JD, Deguzman AF, Ekstrand K, Ellis TL, Glazier SS, McMullen KP, Munley M, Stieber VW, Tatter SB, Shaw EG
Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):208-13. Epub 2008 Aug 5

Wick A, Pascher C, Wick W, Jauch T, Weller M, Bogdahn U, Hau P
Rechallenge with temozolomide in patients with recurrent gliomas
J Neurol. 2009 Feb 25; [Epub ahead of print]